Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
One-Year Clinical Outcomes of Forty-Eight Millimeter Everolimus-Eluting Stent Implanted in Very Long Lesions: A Propensity-Matched Comparison (The FREIUS Study).
Secco GG, Tebaldi M, Parisi R, Cuculo A, Di Mario C, Sangiorgio P, Ielasi A, Centola A, Fattori R, Vercellino M, Longo G, Pistis G, Biscaglia S, Ruggiero A, Marino PN, Campo G. Secco GG, et al. Among authors: parisi r. J Invasive Cardiol. 2018 Apr;30(4):133-137. J Invasive Cardiol. 2018. PMID: 29610443 Free article.
Drug eluting balloon versus drug eluting stent in percutaneous coronary interventions: insights from a meta-analysis of 1462 patients.
Lupi A, Rognoni A, Secco GG, Porto I, Nardi F, Lazzero M, Rossi L, Parisi R, Fattori R, Genoni G, Rosso R, Stella PR, Sheiban I, Bolognese L, Liistro F, Bongo AS, Agostoni P. Lupi A, et al. Among authors: parisi r. Int J Cardiol. 2013 Oct 12;168(5):4608-16. doi: 10.1016/j.ijcard.2013.07.161. Epub 2013 Jul 26. Int J Cardiol. 2013. PMID: 23948110
Similar anti-inflammatory effects of intracoronary and intravenous abciximab during primary percutaneous coronary intervention: a randomized study.
Secco GG, Sansa M, Rognoni A, Parisi R, Fattori R, Rossi L, Lazzero M, Rolla R, Bellomo G, Bongo AS, Agostoni P, Di Mario C, Lupi A. Secco GG, et al. Among authors: parisi r. J Cardiovasc Med (Hagerstown). 2015 Mar;16(3):189-96. doi: 10.2459/JCM.0000000000000119. J Cardiovasc Med (Hagerstown). 2015. PMID: 25022932 Clinical Trial.
Time-related changes in neointimal tissue coverage of a novel Sirolimus eluting stent: Serial observations with optical coherence tomography.
Secco GG, Mattesini A, Fattori R, Parisi R, Castriota F, Vercellino M, Dall'Ara G, Uguccioni L, Marinucci L, De Luca G, Marino PN, Pistis G, Di Mario C. Secco GG, et al. Among authors: parisi r. Cardiovasc Revasc Med. 2016 Jan-Feb;17(1):38-43. doi: 10.1016/j.carrev.2015.12.001. Epub 2015 Dec 19. Cardiovasc Revasc Med. 2016. PMID: 26831901
One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry).
Colombo A, Godino C, Donahue M, Testa L, Chiarito M, Pavon AG, Colantonio R, Cappelletti A, Monello A, Magni V, Milazzo D, Parisi R, Nicolino A, Moshiri S, Fattori R, Aprigliano G, Palloshi A, Caramanno G, Montorfano M, Bedogni F, Margonato A, Briguori C. Colombo A, et al. Among authors: parisi r. Int J Cardiol. 2016 Jul 1;214:113-20. doi: 10.1016/j.ijcard.2016.03.088. Epub 2016 Mar 24. Int J Cardiol. 2016. PMID: 27060269
Polymer-free amphilimus-eluting stent versus biodegradable polymer biolimus-eluting stent in patients with and without diabetes mellitus.
Godino C, Pivato CA, Chiarito M, Donahue M, Testa L, Colantonio R, Cappelletti A, Milazzo D, Parisi R, Nicolino A, Moshiri S, Aprigliano G, Palloshi A, Zavalloni Parenti D, Rutigliano D, Locuratolo N, Melillo F, Scotti A, Arrigoni L, Montorfano M, Fattori R, Presbitero P, Sardella G, Bedogni F, Margonato A, Briguori C, Colombo A; Italian Nobori Stent ProspectIve REgistry-1 (INSPIRE-1) and AmphilimuS iTalian mUlticenTre rEgistry (ASTUTE) investigators. Godino C, et al. Among authors: parisi r. Int J Cardiol. 2017 Oct 15;245:69-76. doi: 10.1016/j.ijcard.2017.06.028. Int J Cardiol. 2017. PMID: 28874301
185 results